Syringe Access, Use & Discard: Context in AIDS Risk Study (NIDA Grant # RO1 DA12569, PI: Merrill Singer, PhD) –Hispanic Health Council, Htfd., CT: Tom.

Slides:



Advertisements
Similar presentations
North Carolina Harm Reduction Coalition. North Carolina Harm Reduction Coalition (NCHRC) is North Carolina’s only comprehensive harm reduction program.
Advertisements

HIV and Safer Sex. HIV: The Basics AIDS is not going away. It is important to protect yourself, and to talk about it with the people you get high with.
Organizing Drug Users for Community & Social Change.
John Coleman.  The title  The topics  Something different – a new framework  The burning questions  Where next?
“Legal” Obstructions to HIV Prevention in Odessa, Ukraine Robert E. Booth, Ph.D.
Do consumers of ecstasy-type pills take preventative measures to avoid bad effects from ecstasy-type pills? Dr Fairlie McIlwraith Associate Professor Rosa.
McCreary Centre Society  Overall alcohol and marijuana use steadily declined from 1998 among Grade 7 to 12’s  Youth who did try alcohol.
New Haven Needle Exchange Program Was it effective in reducing HIV transmission? Was it cost-effective?
Teen Health Perspective Results “Honestly, most issues are mental like anxiety, stress, worry, and over thinking. They do all not need to be treated with.
Neighborhood Variations in Syringe Access, Use, and Discard Robert Heimer, Kaveh Khoshnood, Wei Teng, David Buchanan, Tom Stopka, & Merrill Singer Acknowledgement:
HIV Risk Behaviors and Alcohol Intoxication among Injection Drug Users in Puerto Rico Tomás D. Matos, MS Center for Addiction Studies Universidad Central.
Hepatitis C Awareness and Risky Injection Behaviors among Injection Drug Users in Treatment PT Korthuis 1, D Feaster 2, Z Gomez 2, M Das-Douglas 3, S Tross.
YOUNG PEOPLE WHO INJECT DRUGS Personal stories, lived experiences.
Killing the Pain: Prescription Drug Abuse and Other Risky Behaviors in Rural Appalachia Jennifer R. Havens, PhD, MPH Department of Behavioral Science Center.
Slide 5.1 Topic 5. Supporting programs aimed at reducing the spread of HIV among and from IDU Needle and Syringe Programs Opioid Substitution Treatment.
Topic 3 Strategies that help reduce the transmission of HIV Slide 3.1.
Syringes in Paradise Over 20 Years of Syringe Exchange in Hawai ʿ i Heather Lusk CHOW Project
Overview of Syringe Exchange Programs New York City Police Academy November 24, 2004.
How taking care of oneself could help long term injection drug users remain uninfected with HIV and HCV Peter Meylakhs Samuel R Friedman Pedro Mateu-Gelabert.
Drug Law And Practice: Application to Harm Reduction In Ukraine Galina Kitsenko (1), Nataliya Kitsenko (2), Tatiana Ysipenko (2), Zita Lazzarini (3, 5),
Quintin Reed 11 th grade Age 16 Mission Statement  To Provide a fast service to those who want, need their shoes, sneakers, and boots. Polished, cleaned.
Afghanistan’s Present IDUs-HIV/AIDS Situation and future action plan Dr.Saifur-Rehman NACP Director April,11,2007 Islamic Republic of Afghanistan Ministry.
Connecticut and National Suicide Data: For General Audiences Robert H. Aseltine, Jr., PhD, Professor Sara Wakai, PhD, Assistant Professor, University of.
HIV Infection Among Those with an Injection Drug Use*- Associated Risk, Florida, 2012 Florida Department of Health HIV/AIDS and Hepatitis Section Division.
Housing Counts: A look at Homelessness among People with HIV in Connecticut Eileen McCarthy Connecticut AIDS Residence Coalition May 2004.
Student Notes: In 30 seconds, potential investors need to be taken through the four important questions on the slide. (Covered on pgs and 146.)
First, Introduce Yourself. “Hi, I’m ____. Tell me a little more about your home here.” Start walking through the home with them.
Divergent Patterns of Amphetamine Use in the City and Rural Areas in Northwest Poland Sobeyko J (1), Leszczyszyn-Pynka M (2), Parczewski M (2), Burris.
New Haven-Fairfield Counties End of Year Studies: Ryan White Planning Council New Haven-Fairfield Counties End of Year Studies: Ryan White Planning Council.
Harm Reduction.
Boltushka: Use of Homemade Amphetamine in Odessa, Ukraine
We conducted a cross-sectional study using interviewer- administered surveys and qualitative interviews of young (aged 18-30) of final sample 164 PWID.
The Governance of Care: Mapping Local Influences on IDU Health Interventions in a Polish City Sobeyko J (1)(8), Leszczyszyn-Pynka M (1)(2), Duklas T (7),
Understanding the IDU community and their vulnerabilities 1.
A Good Start: Resilience in Families With a first Baby Irene de Haan BRCSS/SPEaR Colloquium.
Racial/Ethnic Disparities in the HIV and Substance Abuse Epidemics: Communities Responding to the Need Hortensia Amaro, Anita Raj, Rodolfo Vega, Thomas.
Safe Disposal of Used Needles and Syringes 1. Need for Safe Disposal of Used N/S Needle Syringe Exchange Programme (NSEP) is a major component of the.
Building Trust With the Injection Drug Community Megan Hatta, RN.
November 2012 Prepared for the Contra Costa Board of Supervisors by Contra Costa Health Department Needle Exchange Update.
Ethical Challenges for Research- Related HIV Testing and Counseling: Community Perspectives Celia B. Fisher, Ph.D. Marie Ward Doty Professor of Psychology.
Involving People living with HIV/AIDS: What does the Science Tell Us? Mark Tyndall & Thomas Kerr British Columbia Centre for Excellence in HIV/AIDS Dept.
Risk and the Residential Environment: Prior Homelessness as a Predictor of HIV Risk among Adults Living in Single Room Occupancy Housing Elizabeth Bowen,
Social Relationships and Harm Reduction Practice among Injection Drug Users in Nova Scotia Joanne Parker CPHA 2008 Annual Conference Halifax, NS June 1-4,
Final Report for East Carolina University
Tailored Harm Reduction Approaches: Bringing health care and social support to women drug users in Georgia Janna Ataiants, Nino Janashia, Ketevan Bidzinashvili,
Groups and subgroups of drug users Presentation 6.
Hepatitis C and HIV Incidence Among Injecting Drug Users in Kabul, Afghanistan Catherine Todd, Abdul Nasir, M. Raza Stanekzai, M. Zafar Rasuli, Katja Fiekert,
Effects of Pharmacy Syringe Access Among Young Heroin Injectors Results IDU needle sharing decreased after the enactment of the pharmacy access law in.
Jennifer R. Havens, PhD, MPH Associate Professor
1 No glove, no love: Why California’s ethnic youth report using contraception Shelly Koenemann, MPH Marlena Kuruvilla, MPH/MSW Michelle Barenbaum, MPH.
New Networking Strategies How to Develop Your Business and Build Sales Through Social Media Shaa Wasmund.
THE 6 TH NATIONAL SCIENTIFIC CONFERENCE ON HIV/AIDS Social and health benefits of participating in HIV research with people who inject drugs: Experience.
Association for Women in Psychology Conference “A Model of Integrated Treatment for Women with Co-Occurring Disorders who are at High Risk for HIV” Presented.
Housing Status and HIV Risk Behaviors Among Homeless and Housed Persons with HIV in the United States The findings and conclusions in this presentation.
Collaborative Effort of HIV, Domestic Violence and Homeless Service Organizations to Develop Integrated Services as Strategy for HIV Risk Reduction for.
Organizing Drug Users for Public Health Policy Changes 17 th International Conference on the Reduction of Drug Related Harm Jason Farrell, Executive Director.
2006 Home Sellers Survey Bill Stewart High Performance Business Systems, Inc. June 2006 C.A.R. Business Meetings.
Washington, D.C. Nov. 3-7, 2007 Where do all the syringes come from? Pharmacy contribution to needle and syringe distribution in Hanoi, Vietnam Christopher.
Readiness To Change HIV/HCV Risk Behavior Among Young African American IDUs. Edward V Morse, PhD, Tulane University Health Sciences Center, Department.
Non-Medical Staff Knowledge, Beliefs and Practices about HIV and Hepatitis for Injection Drug Users Rowe, KA 1, Tesoriero, JM 1, Heavner, KK 1, Rothman,
Health & Happiness Survey Disability Data May 2016.
Syringe Exchange Programs in NC
Syringe Exchange Programs in NC
Sherry Deren, Sung-Yeon Kang, Milton Mino & Honoria Guarino
Believed discrimination occurred because of their:
Maria A. Carrasco, MPP, MPH, PhD (candidate)
Documenting barriers to access HCV care and treatment: a peer-led research João Santa Maria, Magda Ferreira, Renato Pinto, Joana Sanches, Álvaro Ávila,
Rowe, KA1, Tesoriero, JM1, Davis, SJ1, Heavner, KK1, Rothman, J2,
Community Intervention Strategies
There are over 200 syringe access service programs (SSP) in the United States. These programs provide sterile syringes to people who inject drugs and.
Presentation transcript:

Syringe Access, Use & Discard: Context in AIDS Risk Study (NIDA Grant # RO1 DA12569, PI: Merrill Singer, PhD) –Hispanic Health Council, Htfd., CT: Tom Stopka, MHS, Merrill Singer, PhD, Claudia Santelices, ABD, Wei Teng, PhD, Glenn Scott, Susan Shaw, PhD, Anna Marie Nicolaysen, MA, Julie Eiserman, M.A. –Yale Univ. Dept. of EPH: Robert Heimer, PhD, Kaveh Khoshnood, PhD, Mark Kinzly, Anthony Givens, Kevin Irwin, BS –UMass SPH: David Buchanan, DrPH –New North Citizens’ Council, Spfd.: Antonio Arzola –Spfd. SW Comm. Hlth. Ctr., MA: Sabrina Simmons

Public Health Interventionists, Successful Capitalists, Harbingers of Risk? Syringe Sellers in Connecticut and Massachusetts Tom Stopka 1, Merrill Singer 1, Claudia Santelices 1, Wei Teng 1, Robert Heimer 2, Susan Shaw 1, Anna Marie Nicolaysen 1, Mark Kinzly 2, Kaveh Khoshnood 2, David Buchanan 3, and Glenn Scott 1 1) Hispanic Health Council, Hartford, CT; 2) Yale University, New Haven, CT; 3) University of Massachusetts, Amherst, MA

Need for a New Intervention b10 years since any new public health interventions have been attempted to reduce HIV and Hepatitis transmission among IDUs â SEP â OTC sales of pharmacy syringes â Outreach efforts â Bridge to treatment programs bNeed a new approach âCan syringe sellers fill an important harm reduction niche?

Methods bIn-depth Interviews (N=25): âHartford: 20 IDIs with 18 syringe sellers Springfield: 7 total âHartford: 13 Latino, 3 AA, 1 white, 1 M.E. Springfield: 4 PR, 2 AA, 1 white âHartford: 15 male, 3 female; mean age = 37 Springfield: 3 male, 4 female; mean age = 39 *Syringe sellers difficult to locate in New Haven* bStructured surveys with IDUs (N=878) bEthnographic Observations

Syringe Source Used Most ) Often, Past 30 Days (N=878) Categorization of syringe sellers and diabetics is based on perceptions of IDUs who were interviewed.

Rationale for Selling Syringes bEasy Labor -- “I started hanging around on the corner right over here..., and I saw some people selling syringes, and selling drugs. I had no choice. I don’t do no drugs. And the syringes were easy to sell. So, I said, ‘hell, that is what I am going to do.’” (Hartford) b“ Easy money” b“Insurance source…wouldn’t have to go steal…” b“Less worries” with police bHarm Reduction -- “So I got hepatitis C. That is why I am selling [sterile syringes] now…I don’t want nobody to catch that.” (Hartford Seller)

Typology of Syringe Sellers in Hartford and Springfield bOpportunistic Sellers -- “I got a box of syringes from a friend for a couple of bucks and I sold them.” bBulk Sellers -- “I sell about syringes a day.” bSubcontractors (Hartford) -- “I give you 30 syringes, and what you do is you work this end of the street and I work this end of the street…The more you sell, the more money you make. I give you 30, you give me $20 and you keep ten…”

Clientele bIDUs who... âDon’t want to be seen at SEP or pharmacy (Hartford) âWant to maintain a low profile âFind seller’s schedule and location more convenient bMale (74%) and female (26%) IDUs bRegulars vs. “weekend junkies” (Hartford)

Buyers of Underground Syringes, by Race/Ethnicity (n=121)

IDU Perceptions of Syringe Sellers bHierarchy of Risk ¶Diabetics (non-IDUs) most trusted sellers. “… I know that she is not a drug user. The other sources are drug users and you know, when you are a drug user, you say, no I never touched them and I’m clean. But you know, they ain’t gonna tell you, yeah I’ve got HIV, wanna buy these?” (Hartford IDU) “...it’s just medicine, it’s not like they shooting drugs or anything...” (Springfield IDU) ·“Alcoholics” next most trusted ¸Fellow IDUs least trusted as syringe sellers

Risky Sales “One time a dude asked me, and I had no syringes, and he said he had to get off, I said ‘I got a couple of used ones in the draw’r, but I got Hepatitis,’ so whatever, I said ‘if I give it to you, I am telling you now, you got to clean it.’” (Hartford Seller)

Economy of Syringes I b Variations in price: âSliding scale = $1.00 to $5.00; new and used pricing variation in Springfield âGood days vs. bad days -- “Sundays are my good days. I sell syringes for $2.00. During the week I sell for $1.00.” (Hartford Seller) “Beginning of the month is good for sales.” âAvailability determines price âSyringes sold on credit at higher prices

Economy of Syringes II bStreet sales vs. house sales bSyringes as currency

Syringe Prices, by Source and City

Syringe Sources for Syringe Sellers Diabetics: self, relative Syringe Exchange Program (SEP) Pharmacy: OTC (Hartford), Rx (Spfd.) Injection locales Hospital (stealing) Underground bulk source?

Street Selling Strategies bNew Sellers: “Tengo ganchos” bExperienced sellers: word of mouth b“Sales”: 2 for 1, “…five for two dollars.” b“Referral system” with drug dealers b“One stop deal” bShelter business

Sales Challenges bPolice: “That (possession of syringes) will get you a year in Jail” (Springfield) bNew faces bSyringe inventory depleted quickly (especially around 1st of month in Springfield) bGangs (Hartford) bCompetition

Sterility of Syringes Purchased from Syringe Sellers bHartford: 0 of 59 syringes tested positive for human DNA (new syringes) â37.9% originally from SEP â8.4% individually wrapped bSpringfield: 9 of 76 syringes (11.8%) tested positive for DNA positive (9 used syringes). bNew Haven: 0 of 2 syringes positive (outlier- syringe selling seems very rare)

New Haven bMost participants were reluctant to talk about street sellers. bIDUs shocked by the thought of repackaged syringes. b10 years of increased syringe availability through SEP and pharmacies. bConscious effort by police to shut down syringe sellers. bNo “Street Peddler” tradition.

Conclusions: Syringe Sellers... ¶can improve harm reduction efforts by increasing access to sterile syringes, filling a gap in supply ·may decrease the possibility of IDUs experiencing crisis events with syringes ¸sell more sterile syringes in Hartford than in New Haven and Springfield ¹can play an integral part in future HIV and hepatitis interventions

Operationalizing Syringe Sellers as Public Health Advocates bConduct further research about public health risks and benefits of street sellers. bEducate sellers on safe sales practices. bAdvise IDUs on purchase precautions. bEncourage street sellers to sell/hand out harm reduction materials (e.g., water, cookers, etc.). bConsider creating a formal relationship between DPH and street syringe sellers.